← Leaderboards
Jane F Ferguson
Vanderbilt University Medical Center
$4,116,241
Attributed
$5,473,586
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,473,586 · 3
By mechanism
R01$5,211,086 · 2
R21$262,500 · 1
Top collaborators
- Jonathan David Mosley5 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Wei-Qi Wei$9,737,275
- Dan M Roden$145,793,078
- Jonathan David Mosley$3,613,133
- Lisa Bastarache$6,344,381
- Vern Eric Kerchberger$844,964
Others in their field
Other Emerging Leaders on “New Therapeutic Target”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Priyamvada Acharya · Duke University$26,203,983
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
New Therapeutic TargetBiological MarkersDiabetes MellitusPlasmaMorbidity - Disease RateMortalitySamplingBloodGeneticBlood SpecimenAcuteGenetic PredictorsMetabolismMetabolomicsGenotypeBiologyMeasurementBiologicalCohortCostBiobankEpidemiologyCommunitiesGenome Wide Association Study
Grant awards (12)
The role of alpha-aminoadipic acid (2-AAA) in residual CVD risk in T2D$131,250
R21 · FY2024 · HL · contact PI
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology$542,938
R01 · FY2023 · HL · contact PI
The role of alpha-aminoadipic acid (2-AAA) in residual CVD risk in T2D$131,250
R21 · FY2023 · HL · contact PI
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology$542,938
R01 · FY2022 · HL · contact PI
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes$465,580
R01 · FY2022 · DK · contact PI
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology$542,938
R01 · FY2021 · HL · contact PI
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes$465,580
R01 · FY2021 · DK · contact PI
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes$564,212
R01 · FY2020 · DK · contact PI
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology$542,938
R01 · FY2020 · HL · contact PI
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes$588,875
R01 · FY2019 · DK · contact PI
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology$542,938
R01 · FY2019 · HL · contact PI
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes$412,149
R01 · FY2018 · DK · contact PI